Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / articles / TECH - AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report | Benzinga

TECH - AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report | Benzinga

Bio-Techne Corp

AstraZeneca plc (NASDAQ: AZN) has reportedly finalized a partnership deal valued at up to $247 million with Absci Corporation (NASDAQ: ABSI), a U.S.-based firm specializing in artificial intelligence (AI) applications, aiming to develop an antibody to combat cancer. 

This collaboration underscores the escalating trend of integrating AI technology into pharmaceutical research.

The partnership aims to utilize Absci's advanced AI technology for extensive protein analysis, primarily identifying a viable cancer treatment.

In the Financial Times Full story available on Benzinga.com
Stock Information
Company Name: Bio-Techne Corp
Stock Symbol: TECH
Market: NASDAQ
Website: bio-techne.com
Menu
TECH TECH Quote TECH Short TECH News TECH Articles TECH Message Board
Get TECH Alerts

News, Short Squeeze, Breakout and More Instantly...